Whitnell & Co. »

Takeda Pharmaceutical shares owned by Whitnell & Co.

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Whitnell & Co. from 13F filings

Historical chart of Whitnell & Co. investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Whitnell & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Whitnell & Co.

Quarter filed Position value Share count Share price at filing
2019-12-31 $10k 511 19.57
2019-09-30 $9.0k 511 17.61
2019-06-30 $9.0k 511 17.61
2019-03-31 $10k 511 19.57

More positions owned by Whitnell & Co.

Schwab Strategic Tr us reit etf (SCHH)
First Tr Exchange-traded Fd no amer energy (EMLP)
Apple (AAPL)
Fiserv (FI)
Vanguard Intl Equity Index F glb ex us etf (VNQI)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf (SPY)
iShares MSCI EAFE Index Fund (EFA)
Berkshire Hathaway (BRK.B)
Vanguard Europe Pacific ETF (VEA)
McDonald's Corporation (MCD)
Procter & Gamble Company (PG)
Walt Disney Company (DIS)
Intel Corporation (INTC)
iShares Russell Midcap Growth Idx. (IWP)

View all positions for Whitnell & Co.

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Mondrian Investment Partners
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Millennium Management
Brandes Investment Partners
Renaissance Technologies
First Trust Advisors
FMR
Van Eck Associates Corp.
BlackRock
Citadel Advisors
Northern Trust
Managed Asset Portfolios
Envestnet Asset Management

View all funds holding Takeda Pharmaceutical